IP Verse

Virbac patent opposition analysis

Get complete Patent Opposition Report for Virbac

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Virbac

Explore patent oppositions filed by Virbac against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3707128	Injectable Isoxazoline Pharmaceutical Compositions And Their Use Against Parasite Infestation	INTERVET	Sep 16, 2024
EP4153133	Injectable Pharmaceutical Compositions And Uses Thereof	INTERVET	Jul 31, 2024
EP2488145	Containers For Compositions Comprising Meloxicam	BOEHRINGER INGELHEIM VETMEDICA	Apr 25, 2024
EP3035958	Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Jul 25, 2023
EP2658541	Topical Localized Isoxazoline Formulation Comprising Glycofurol	INTERVET	Oct 25, 2022
EP2658542	Topical Localized Isoxazoline Formulation	INTERVET	Oct 25, 2022
EP3113774	Compositions Of Grapiprant And Methods For Using The Same	ARATANA THERAPEUTICS	Oct 25, 2022
EP3473101	Isoxazoline Compositions And Their Use As Antiparasitics For Felines	INTERVET	Feb 11, 2022
EP2545777	Isoxazoline Compositions And Their Use As Antiparasitics	INTERVET	Dec 11, 2020
EP3079474	Antiparasitic Use Of Isoxazoline Compounds	INTERVET	Apr 3, 2020

Latest patents of Virbac opposed by its competitors

Explore Virbac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2789627	Sep 27, 2017	Porcine Circovirus Type-2 Subunit Vaccine	1

Top competitors of Virbac

INTERVET

BOEHRINGER INGELHEIM ANIMAL HEALTH USA

BOEHRINGER INGELHEIM VETMEDICA